USCDI Export for the Public

Classification Level Sort descending Data Class Data Class Description Data Element Data Element Description Applicable Standards Submitter Name Submitter Organization Submission Date
USCDI V3.1

Unique identifier(s) for a patient's implantable device(s).

Unique numeric or alphanumeric codes that consist of a device identifier and a production identifier.

  • FDA Unique Device Identification System (UDI System)
Marti Velezis FDA/CDRH/Indira Konduri (FDA/CDRH/OPEQ/ORP/DRPIII)
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions.

Both standards are required

  • Logical Observation Identifiers Names and Codes (LOINC®) version 2.72
  • The Unified Code of Units for Measure, Revision 2.1
USCDI V3.1

Harmful or undesired physiological responses associated with exposure to a substance.

Pharmacologic agent believed to cause a harmful or undesired physiologic response following exposure.

  • RxNorm® Full Monthly Release, July 5, 2022
USCDI V3.1

Harmful or undesired physiological responses associated with exposure to a substance.

Pharmacologic category for an agent believed to cause a harmful or undesired physiologic response following exposure.

  • SNOMED International, Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT®) U.S. Edition, March 2022 Release
USCDI V3.1

Harmful or undesired physiological responses associated with exposure to a substance.

Harmful or undesired physiologic response following exposure to a pharmacologic agent or class of agents.

  • SNOMED International, Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT®) U.S. Edition, March 2022 Release
USCDI V3.1

Data used to categorize individuals for identification, records matching, and other purposes.

Prior place where a person may have been located or could have been contacted.

  • Project US@ Technical Specification for Patient Addresses, Final Version 1.0
USCDI V3.1

Data used to categorize individuals for identification, records matching, and other purposes.

Contact point when using a phone (e.g., home, work, mobile).

USCDI V3.1

Data used to categorize individuals for identification, records matching, and other purposes.

Unique identifier of an individual's email account that is used to send and receive email messages.

USCDI V3.1

Information related to interactions between healthcare providers and a patient.

Category of health care service. (e.g., office visit, telephone assessment, home visit)

Joel Andress Centers for Medicare and Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ)